Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 6OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 5Thoracic 4Tumor-Agnostic 3Lymphoid 3Gastrointestinal 3Dermatologic 3CNS 3Breast 3Head & Neck 2Genitourinary 2Sarcoma 1Plasma cell 1Myeloid 1Gynecologic 1Endocrine 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × entrectinib × Thoracic × Clear all
NCT07199959 2025-09-30

Study on the Mechanism of Acquired Resistance of Entrectinib

Fudan University

Recruiting
38 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06694129 2024-11-19

Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

National Cancer Center, China

Not yet recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04322890 2024-10-22

PIKACHU

Hunan Province Tumor Hospital

Phase 2 Recruiting
6,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04591431 2023-10-03

ROME

Fondazione per la Medicina Personalizzata

Phase 2 Unknown
400 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡